Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,14118,160 of 20,252 grants

Completed SBIR-STTR RPGS
Developing a RPN13 inhibitor for the treatment of Quadruple Negative Breast Cancer
NATIONAL CANCER INSTITUTE Up Therapeutics, Inc United States 2021 – 2023

Quadruple negative breast cancer (QNBC), lacking the expression of ER (estrogen receptor), PR (progesterone receptor), HER2 (human epidermal growth factor receptor 2) and AR (andro...

$2.54M
USD
Active NON-SBIR/STTR RPGS
Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2027

ABSTRACT: In 2019, an estimated 228,150 patients in the US are expected to be diagnosed with non-small cell lung cancer (NSCLC). A recent landmark development has been the approval...

$10
USD
Active NON-SBIR/STTR RPGS
Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2027

ABSTRACT: In 2019, an estimated 228,150 patients in the US are expected to be diagnosed with non-small cell lung cancer (NSCLC). A recent landmark development has been the approval...

$5.07M
USD
Completed NON-SBIR/STTR RPGS
Mitochondrial heterogeneity as the origin of chemoresistance in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

Summary Therapeutic resistance and tumor relapse present as major barriers to achieving a definitive cure for cancer. This challenge is especially relevant for patients with pancre...

$4.37M
USD
Completed TRAINING, INSTITUTIONAL
Team-based Interdisciplinary Cancer Research Training Program
NATIONAL CANCER INSTITUTE University of Florida United States 2021 – 2026

TEAM-BASED INTERDISCIPLINARY CANCER RESEARCH TRAINING PROGRAM PROJECT SUMMARY/ABSTRACT In advancing innovative ways to address complex cancer challenges, there is a growing trend t...

$2.59M
USD
Completed NON-SBIR/STTR RPGS
Investigation of the role of epithelial-mesenchymal plasticity in renal cell carcinoma
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

Sarcomatoid renal cell carcinoma (sRCC) represents an aggressive group of renal epithelial tumors characterized by histopathological features of epithelial–mesenchymal plasticity (...

$6M
USD
Completed OTHER RESEARCH-RELATED
Increasing physical activity among breast cancer survivors: Use of the ORBIT Model to refine and test a novel approach to exercise promotion based on affect-regulation
NATIONAL CANCER INSTITUTE Dartmouth-Hitchcock Clinic United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT The goal of this K08 Mentored Clinical Scientist Research Career Development Award is to prepare the candidate for an independent research career Breast ca...

$1.74M
USD
Completed NON-SBIR/STTR RPGS
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2021 – 2026

PROJECT SUMMARY Ovarian cancer is a silent killer that strikes with few, if any, symptoms. By the time a woman knows she has it, the cancer is often advanced and the outlook grim....

$2.98M
USD
Completed NON-SBIR/STTR RPGS
Robot-Assisted Personalized Prostate Biopsy
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Prostate cancer (PCa) is the most commonly diagnosed type of cancer and the second leading cause of cancer related death among US men. The best current est...

$2.96M
USD
Completed NON-SBIR/STTR RPGS
Live cell reporters of genetic changes in stiff vs soft surroundings - Causes & Consequences
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2026

Project Abstract Live cell reporters of genetic changes in stiff vs soft surroundings – causes & consequences Solid tumors are often palpably stiff and more constrained in 3D g...

$7.57M
USD
Completed NON-SBIR/STTR RPGS
Oligo(lactic acid)n-Prodrug Nanomedicines for Combination Therapy
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2025

Project Summary/Abstract Taxol is commonly used to treat TNBC and increasingly in combination with oral signal transduction inhibitors (STIs), such as mTOR inhibitor (Afinitor) a...

$3.31M
USD
Completed SBIR-STTR RPGS
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
NATIONAL CANCER INSTITUTE Rise Therapeutics, Llc United States 2021 – 2025

Project Summary The goal of this project is to develop a novel oral drug, R-5780, which engages microbiome-associated Pattern Recognition Receptors (PRRs) to enhance the activity o...

$1.71M
USD
Active NON-SBIR/STTR RPGS
Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction
NATIONAL CANCER INSTITUTE Lankenau Institute for Medical Research United States 2021 – 2026

ABSTRACT E2f (E2f1-8) transcription factors are critical regulators of cell cycle and their activity is physically regulated by Rb family proteins (Rb, p107 and p130). Disruption o...

$3.61M
USD
Completed OTHER RESEARCH-RELATED
The Pediatric Advanced Cancer Experience (PACE): Measuring Quality of End-of-Life Care for Children with Cancer
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2026

PROJECT SUMMARY Although cure rates for childhood cancer have increased over several decades, cancer remains the leading cause of non-accidental death in children. Yet, there are n...

$2.21M
USD
Active NON-SBIR/STTR RPGS
Novel Optimization Methods and Treatment Planning System for Clinically-Deliverable Truly-Hybrid Proton-Photon Radiotherapy
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2021 – 2026

Project Summary Radiotherapy (RT) aims to deliver tumoricidal dose to clinical target volume (CTV) while sparing organs at risk (OAR), for which proton and photon beams are natural...

$3.37M
USD
Completed SBIR-STTR RPGS
Optimizing Radiosynthetic Yield of [18F]FTT For Wide-Spread Distribution
NATIONAL CANCER INSTITUTE Trevarx Biomedical, Inc United States 2021 – 2025

ABSTRACT: Poly (ADP-ribose) polymerase inhibitors (PARPi’s) have emerged as important therapeutic agents targeting a broadening class of gene mutations approved for treatment of br...

$9.79M
USD
Active NON-SBIR/STTR RPGS
Breast Cancer Intravoxel-incoherent-motion MRI Multisite (BRIMM) Study - Resubmission - 1
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2021 – 2026

PROJECT SUMMARY While the technological enterprise of magnetic resonance imaging (MRI) generates a host of biomarkers of the tumor environment, in particular for breast cancer, pre...

$4.94M
USD
Completed NON-SBIR/STTR RPGS
Relaxed Polymerase Pausing as a Driver of Epigenetic Plasticity and Cancer Cell Invasion
NATIONAL CANCER INSTITUTE University of Rochester United States 2021 – 2026

Project Summary The development of distant metastases accounts for a significant proportion of breast cancer mortality; as many as 30% of patients initially diagnosed at an early s...

$563.8K
USD
Completed NON-SBIR/STTR RPGS
Mechanisms of metabolic stress-induced transcriptional regulation in prostate cancer
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2021 – 2026

Metastatic prostate cancer (PCa) remains a major clinical challenge. Although androgen deprivation therapy (ADT) is effective in treating PCa, majority of the patients quickly deve...

$602.3K
USD
Completed NON-SBIR/STTR RPGS
Effectiveness and implementation of a health system intervention to improve quality of cancer care for rural, underserved patients
NATIONAL CANCER INSTITUTE University of Iowa United States 2021 – 2026

PROJECT SUMMARY There is growing evidence that limited access to high-quality cancer treatment is one of the main drivers of higher cancer mortality rates among rural cancer patien...

$1.71M
USD